Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Invion ( (AU:IVX) ) has issued an update.
Invion Limited has announced a change in the interests of its director, Chiat Thian Chew, involving the lapse and cancellation of 1,384,886 unlisted options without conversion. This adjustment in the director’s securities holdings reflects a strategic decision that may impact the company’s governance and shareholder dynamics.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on the development of treatments for chronic inflammatory diseases. The company is involved in the research and commercialization of pharmaceutical products.
Average Trading Volume: 120,749
Technical Sentiment Signal: Sell
Current Market Cap: A$10.28M
For an in-depth examination of IVX stock, go to TipRanks’ Overview page.